Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07711015
Starting soon Not applicable

Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury

NCT07711015 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2026-08-17
Last updated
2026-07-17

Condition(s) studied

Spinal Cord Injuries (SCI)

Investigational drug(s) / intervention(s)

Myofascial Release

Myofascial Release: Manual myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion, including the biceps brachii, brachialis, and triceps muscles. The intervention will be performed by a trained physiotherapist using a handheld device, with 90 seconds of application per muscle group. The treatment will be administered immediately prior to the 20-meter wheelchair sprint test

Study summary

This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury.

Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the intervention.

The myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion using a handheld device for 90 seconds per muscle group.

Sprint performance will be measured by the time required to complete the 20-meter distance.

The study will compare performance between conditions to determine whether myofascial release improves speed.

Eligibility

Sex
ALL
Min age
18 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Men and women * Aged 18 years or older * Cervical spinal cord injury (tetraplegia) * Practice of wheelchair rugby for at leastm12 months * Participating in team training sessions for at least 3 months prior to the study. Exclusion Criteria: * Musculoskeletal pain * Injury that prevents completion of the study protocol. * Wounds, pressure ulcers, or skin lesions at the site of myofascial release application * Recreational athletes * Medical contraindication to manual therapy * Infection, fever, or acute illness at the time of assessment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centro Universitário Augusto Motta Rio de Janeiro Rio de Janeiro

More Centro Universitário Augusto Motta trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07711015 on ClinicalTrials.gov ↗ ← All trials in Brazil